Home › Gilead Has Bottomed - The Question Is How Much Upside Ahead?
 

Keywords :   


Gilead Has Bottomed - The Question Is How Much Upside Ahead?

2016-02-16 05:34:09| Biotech - Topix.net

It has been a frightful six months for biotech investors as the main biotech indices have plunged some 40% from their peaks in July. However, it does appear the some of the big biotech names are in a bottoming phase which is needed before the sector can rally.

Tags: much question ahead upside

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05IT Cosmetics and Kenvue Launch New Products
19.05Virgin Trains targets West Coast in return to rail
19.05Cashing In On The Stache
19.05 Dr. Squatch Launches Bronco Bricc
More »